- Events
- GenAI Loft London - Day 3 [Morning Session]: Shaping the next wave
GenAI Loft London - Day 3 [Morning Session]: Shaping the next wave
AWS GenAI Loft | Londres
Jour:
-
Heure:
-
Type:
EN PRÉSENTIEL
Langue:
English
Niveau(x):
100 – Élémentaire
Where founders, investors, and innovators meet to uncover the breakthroughs reshaping entire markets.
Day 3 begins with a high-level look at the forces setting the pace of disruption. This isn’t speculation — it’s the sectors already being redefined by generative AI, and the opportunities and risks that come with them. Venture capital leaders reveal where capital is flowing, biotech pioneers show how AI is accelerating discovery, and operators debate which industries will feel the heaviest shockwaves from agentic software.
From autonomous agents and defense tech, to precision medicine and vertical SaaS, the conversations in this track move beyond hype into the realities of where innovation is advancing fastest. It’s a chance to hear directly from those shaping tomorrow’s markets — and to understand where founders and investors should focus today to capture the outsized opportunities ahead.
Why attend:
To cut through noise and gain clarity on the markets, technologies, and sectors where generative AI is already rewriting the rules — and where disruption is inevitable next.
Who should attend:
Founders, investors, and ecosystem leaders who want a clear view of which industries are primed for transformation and how to position themselves at the forefront.
Agenda
8:30 AM UTC
Emerging tech trends
Has autonomous and agentic AI truly arrived? How much are VCs actually investing in defence tech? What's all the hype around application-specific chips? This dynamic panel brings together leading venture capital investors who've backed some of our most successful and disruptive startups to discuss reveal their insights on the technologies shaping tomorrow's success stories, and where they're placing their bets for the future.
9:25 AM UTC
Riding the AI revolution in techbio and life sciences
Join pioneering investors and biotech leaders as they explore how AI is revolutionizing drug discovery, molecular design, and precision medicine. Our expert panellists will examine how artificial intelligence is dramatically accelerating research timelines, unlocking new therapeutic possibilities, and transforming traditional R&D approaches in life sciences. Learn how the convergence of AI and biological science is creating unprecedented possibilities for treating disease, extending human healthspan, and reshaping the future of healthcare innovation.
10:20 AM UTC
Primed for disruption - which sectors will agentic vertical SaaS hit hardest?
With so much discussion on the transformative impact of agentic software it seems likely that no industry will be spared disruption. But which sectors will truly be hit the hardest? Are we facing a future with fewer lawyers? Or is it 'ta ta' to travel agents? Our expert panel of investors and entrepreneurs cut through the noise to share fresh insights about where the biggest opportunities lie, which industries are about to experience the most fundamental change, and where they are putting their smart money for the future.